This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Dr. Stefano Zanotti, PhD
SVP, Head of Neuromuscular Research at Dyne Therapeutics
Speaker

Profile

Stefano Zanotti, Ph.D. heads the Genetic Medicines Research department at Dyne Therapeutics, where he oversees a multidisciplinary research team dedicated to advancing Dyne pipeline by discovering and developing treatments for genetic disorders. Stefano has committed his scientific career to genetic disorders; prior to joining Dyne, he was Director of Rare Renal and Musculoskeletal Diseases at Sanofi. Prior to Sanofi, Stefano was Assistant Professor at the University of Connecticut School of Medicine, where he conducted NIH-funded research focused on genetic disorders of the skeletal system. Stefano has published numerous reviews, book chapters, and more than 50 research articles in major scientific journals; he is also an inventor on several patents in the field of oligonucleotide design and targeted drug delivery.

Agenda Sessions

  • Unlocking the Therapeutic Potential of Oligonucleotides for CNS Disorders Through Targeted Delivery

    11:15am